T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ILPT
2826
Industrial Logistics Properties Trust
ILPT
$608M
| $181K | ﹤0.01% |
32,541
+4,099
| +14% | +$22.7K |
|
2827
Bally's
BALY
$668M
| $178K | ﹤0.01% |
+10,733
| New | +$175K |
|
2828
TTEC Holdings
TTEC
$80.4M
| $176K | ﹤0.01% |
48,752
| – | – |
|
|
NPB
2829
Northpointe Bancshares
NPB
$604M
| $176K | ﹤0.01% |
+10,446
| New | +$177K |
|
2830
Funko
FNKO
$338M
| $175K | ﹤0.01% |
51,276
+6,500
| +15% | +$20.4K |
|
2831
Blue Ridge Bankshares
BRBS
$337M
| $172K | ﹤0.01% |
40,147
+1,205
| +3% | +$5.23K |
|
2832
Canterbury Park Holding Corp
CPHC
$80.1M
| $172K | ﹤0.01% |
11,247
| – | – |
|
2833
Tonix Pharmaceuticals
TNXP
$214M
| $171K | ﹤0.01% |
+10,933
| New | +$202K |
|
|
FVR
2834
FrontView REIT
FVR
$484M
| $171K | ﹤0.01% |
11,553
+406
| +4% | +$5.83K |
|
2835
Comtech Telecommunications
CMTL
$53M
| $169K | ﹤0.01% |
31,864
| – | – |
|
2836
Target Hospitality
TH
$1.64B
| $169K | ﹤0.01% |
21,054
+4,706
| +29% | +$35.7K |
|
2837
ADC Therapeutics
ADCT
$132M
| $166K | ﹤0.01% |
46,750
+9,537
| +26% | +$38.7K |
|
2838
OneWater Marine
ONEW
$203M
| $166K | ﹤0.01% |
+15,260
| New | +$204K |
|
2839
Anavex Life Sciences
AVXL
$303M
| $165K | ﹤0.01% |
46,279
+669
| +1% | +$4.1K |
|
|
HSHP
2840
Himalaya Shipping
HSHP
$739M
| $164K | ﹤0.01% |
17,932
+2,622
| +17% | +$22.2K |
|
2841
Hurco Companies Inc
HURC
$144M
| $164K | ﹤0.01% |
+10,600
| New | +$176K |
|
2842
Boston Omaha
BOC
$431M
| $163K | ﹤0.01% |
13,117
+1,866
| +17% | +$24.3K |
|
2843
Delcath Systems
DCTH
$596M
| $163K | ﹤0.01% |
16,076
| – | – |
|
2844
TAL Education Group
TAL
$6.39B
| $163K | ﹤0.01% |
14,900
-6,161
| -29% | -$70K |
|
2845
Arcturus Therapeutics
ARCT
$223M
| $161K | ﹤0.01% |
26,114
-1,838
| -7% | -$19.9K |
|
2846
Ooma
OOMA
$574M
| $160K | ﹤0.01% |
13,576
| – | – |
|
2847
Red Robin
RRGB
$186M
| $159K | ﹤0.01% |
39,087
| – | – |
|
2848
Stem
STEM
$55.5M
| $159K | ﹤0.01% |
10,514
-1,825
| -15% | -$35K |
|
2849
KORU Medical Systems
KRMD
$153M
| $158K | ﹤0.01% |
27,036
+5,649
| +26% | +$27.1K |
|
2850
Portillo's
PTLO
$368M
| $158K | ﹤0.01% |
34,765
+5,109
| +17% | +$26.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.